Get Aklief Online

Aklief (trifarotene) is a fourth-generation topical retinoid cream. It selectively activates retinoic acid receptor gamma (RAR-gamma) in skin cells, which normalizes the skin cell turnover process inside hair follicles, prevents comedone formation, and reduces inflammatory acne lesions. It is the first topical retinoid specifically approved for acne on both the face and the trunk.

Apply a thin layer of Aklief once daily in the evening to clean, dry skin on the affected areas of the face and/or trunk. Avoid the eyes, lips, and mucous membranes. Using a gentle, non-comedogenic moisturizer can help manage dryness or irritation, especially during the first few weeks of use.

Most patients begin to notice improvement after 8 to 12 weeks of consistent use. Some patients experience an initial worsening of acne during the first 2 to 4 weeks, which is a common retinoid adjustment phase. Continuing treatment as directed is important for achieving the best outcome.

The most common side effects are local skin reactions including dryness, redness, scaling, and stinging or burning at the application site. These effects are typically mild to moderate and often improve as the skin adjusts to the medication over the first few weeks. Using a moisturizer and applying sunscreen daily can help reduce irritation.

Yes. Aklief is specifically approved for acne on the face, chest, shoulders, and back. This makes it one of the few topical retinoids with a clinical indication that covers truncal acne. Your physician will advise on the proper amount to use for each area.

You should avoid using other potentially irritating topical products at the same time, such as abrasive cleansers, products containing high-concentration benzoyl peroxide, alcohol-based toners, or other retinoids, unless directed by your physician. Waxing treated skin is not recommended due to increased sensitivity. Always tell your prescribing doctor about all products and medications you are currently using.

Trifarotene, like all retinoids, carries potential risks in pregnancy. Aklief is not recommended for use during pregnancy. If you are pregnant, planning to become pregnant, or breastfeeding, inform your physician before starting this medication so that a safer alternative can be considered.

Doctronic uses an AI-powered evaluation to gather detailed information about your symptoms, medical history, and current medications. A licensed physician then reviews your case, makes a clinical decision, and, if appropriate, creates a personalized treatment plan that may include a prescription. The entire process is HIPAA-compliant and available to adults 18 and older in any U.S. state.